Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model

Virology Journal

Volumn 9, Issue , 2012, Pages

  Li, Yize ^a   Counor, Dorian ^a   Lu, Peng ^a   Duong, Veasna ^b   Yu, Yongxin ^c   Deubel, Vincent ^a,b  

^a Chinese Academy of Sciences   (China)

^b INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^c NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

Author keywords

Japanese encephalitis virus; Monoclonal antibodies; Mouse model; NS1 protein; T cell response, Antibodies

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; JAPANESE ENCEPHALITIS VACCINE; NONSTRUCTURAL PROTEIN 1; WATER; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; NS1 PROTEIN, FLAVIVIRUS; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DROSOPHILA; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOPROPHYLAXIS; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE; ANIMAL; BLOOD; C3H MOUSE; CELL LINE; DISEASE MODEL; IMMUNOLOGY; MONONUCLEAR CELL; PASSIVE IMMUNIZATION; SECRETION (PROCESS); SPLEEN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CELL LINE; DISEASE MODELS, ANIMAL; DROSOPHILA; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; INTERFERON-GAMMA; JAPANESE ENCEPHALITIS VACCINES; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED C3H; SPLEEN; VACCINES, SYNTHETIC; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84865103411     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-135     Document Type: Article

References (53)

1. Emerging zoonotic encephalitis viruses: lessons from Southeast Asia and Oceania. Mackenzie JS, J Neurovirol 2005 11 434 440 10.1080/13550280591002487 16287684
2. Flavivirus genome organization, expression, and replication. Chambers TJ, Hahn CS, Galler R, Rice CM, Annu Rev Microbiol 1990 44 649 688 10.1146/annurev.mi.44.100190.003245 2174669
3. Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function. Lindenbach BD, Rice CM, J Virol 1999 73 4611 4621 10233920
4. Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein. Gutsche I, Coulibaly F, Voss JE, Salmon J, D'Alayer J, Ermonval M, Larquet E, Charneau P, Krey T, Megret F, et al. Proc Natl Acad Sci USA 2011 108 8003 8008 10.1073/pnas.1017338108 21518917
5. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Chung KM, Liszewski MK, Nybakken G, Davis AE, Townsend RR, Fremont DH, Atkinson JP, Diamond MS, Proc Natl Acad Sci USA 2006 103 19111 19116 10.1073/pnas.0605668103 17132743
6. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. Avirutnan P, Fuchs A, Hauhart RE, Somnuke P, Youn S, Diamond MS, Atkinson JP, J Exp Med 2010 207 793 806 10.1084/jem.20092545 20308361
7. Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. Avirutnan P, Hauhart RE, Somnuke P, Blom AM, Diamond MS, Atkinson JP, J Immunol 2011 187 424 433 10.4049/jimmunol.1100750 21642539
8. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Falconar AKI, Arch Virol 1997 142 897 916 10.1007/s007050050127 9191856
9. Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen. Chang HH, Shyu HF, Wang YM, Sun DS, Shyu RH, Tang SS, Huang YS, J Infect Dis 2002 186 743 751 10.1086/342600 12198607
10. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. Lin CF, Lei HY, Shiau AL, Liu HS, Yeh TM, Chen SH, Liu CC, Chiu SC, Lin YS, J Immunol 2002 169 657 664 12097367
11. Ixiaro: a new vaccine against Japanese encephalitis. Jelinek T, Expert Rev Vaccines 2009 8 1501 1511 10.1586/erv.09.112 19863241
12. Japanese encephalitis in travelers from non-endemic countries, 1973-2008. Hills SL, Griggs AC, Fischer M, Am J Trop Med Hyg 2010 82 930 936 10.4269/ajtmh.2010.09-0676 20439978
13. Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. Schlesinger JJ, Brandriss MW, Cropp CB, Monath TP, J Virol 1986 60 1153 1155 3783816
14. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal Dengue virus encephalitis. Falgout B, Bray M, Schlesinger JJ, Lai CJ, J Virol 1990 64 4356 4363 2143542
15. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus nonstructural proteins, NS1, NS2a and NS2b. Putnak JR, Schlesinger JJ, J Gen Virol 1990 71 1697 1702 10.1099/0022-1317-71-8-1697 2144016
16. Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus nonstructural glycoprotein NS1. Jacobs SC, Stephenson JR, Wilkinson GWG, J Gen Virol 1994 75 2399 2402 10.1099/0022-1317-75-9-2399 8077939
17. Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein. Timofeev AV, Ozherelkov SV, Pronin AV, Deeva AV, Karganova GG, Elbert LB, Stephenson JR, J Gen Virol 1998 79 Pt 4 689 695 9568962
18. Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses. Schepp-Berglind J, Luo M, Wang D, Wicker JA, Raja NU, Hoel BD, Holman DH, Barrett AD, Dong JY, Clin Vaccine Immunol 2007 14 1117 1126 10.1128/CVI.00070-07 17634508
19. Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice. Wu SF, Liao CL, Lin YL, Yeh CT, Chen LK, Huang YF, Chou HY, Huang JL, Shaio MF, Sytwu HK, Vaccine 2003 21 3919 3929 10.1016/S0264-410X(03)00310-4 12922127
20. Genetic vaccination of mice with plasmids encoding the NS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus. Timofeev AV, Butenko VM, Stephenson JR, Virus Genes 2004 28 85 97 14739654
21. Synergistic interactions of anti-NS1 monoclonal-antibodies protect passively immunized mice from lethal challenge with dengue-2 virus. Henchal EA, Henchal LS, Schlesinger JJ, J Gen Virol 1988 69 2101 2107 10.1099/0022-1317-69- 8-2101 3404125
22. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Schlesinger JJ, Foltzer M, Chapman S, Virology 1993 192 132 141 10.1006/viro.1993.1015 8517015
23. Antibodies against West Nile virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. Chung KM, Nybakken GE, Thompson BS, Engle MJ, Marri A, Fremont DH, Diamond MS, J Virol 2006 80 1340 1351 10.1128/JVI.80.3.1340-1351.2006 16415011
24. Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile virus-infected cells. Chung KM, Thompson BS, Fremont DH, Diamond MS, J Virol 2007 81 9551 9555 10.1128/JVI.00879-07 17582005
25. Protection of mice against lethal Japanese encephalitis with a recombinant baculovirus vaccine. McCown J, Cochran M, Putnak R, Feighny R, Burrous J, Henchal E, Hoke C, Am J Trop Med Hyg 1990 42 491 499 2160199
26. Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus. Konishi E, Pincus S, Fonseca BAL, Shope RE, Paoletti E, Mason PW, Virology 1991 185 401 410 10.1016/0042-6822(91)90788-D 1833876
27. A specific and sensitive antigen capture assay for NS1 protein quantitation in Japanese encephalitis virus infection. Li YZ, Counor D, Lu P, Liang GD, Huong VT, Nga PT, Loan HT, Sun G, Grandadam M, Butrapet S, et al. J Virol Methods 2011 179 8 16 21704081
28. Mice with different susceptibility to Japanese encephalitis virus infection show selective neutralizing antibody response and myeloid cell infectivity. Wang K, Deubel V, PLoS One 2011 6 24744 10.1371/journal.pone. 0024744 21949747
29. Structure of the dengue virus envelope protein after membrane fusion. Modis Y, Ogata S, Clements D, Harrison SC, Nature 2004 427 313 319 10.1038/nature02165 14737159
30. Functional diversity of helper T lymphocytes. Abbas AK, Murphy KM, Sher A, Nature 1996 383 787 793 10.1038/383787a0 8893001
31. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines. Aucouturier J, Dupuis L, Deville S, Ascarateil S, Ganne V, Expert Rev Vaccines 2002 1 111 118 10.1586/14760584.1.1.111 12908518
32. Protective immunity of Ecoli-synthesized NS1 protein of Japanese encephalitis virus. Lin CW, Liu KT, Huang HD, Chen WJ, Biotechnol Lett 2008 30 205 214 10.1007/s10529-007-9529-9 17876533
33. The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity. Alcon-LePoder S, Drouet MT, Roux P, Frenkiel MP, Arborio M, Durand-Schneider AM, Maurice M, Le Blanc I, Gruenberg J, Flamand M, J Virol 2005 79 11403 11411 10.1128/JVI.79.17.11403-11411.2005 16103191
34. A L.E.A.P.S.TM heteroconjugate vaccine containing a T cell epitope from HSV-1 glycoprotein D elicits Th1 responses and protection. Goel N, Rong Q, Zimmerman D, Rosenthal KS, Vaccine 2003 21 4410 4420 10.1016/S0264-410X(03) 00429-8 14505924
35. Recognition of nonstructural protein-peptides by cytotoxic T lymphocytes raised against Japanese encephalitis virus. Murali-Krishna K, Ramireddy B, Ravi V, Manjunath R, Microbiol Immunol 1995 39 1021 1024 8789064
36. Japanese encephalitis virus infection of mouse cell lines: ability to prime mice for generation of virus-specific cytotoxic T lymphocytes and differences in CTL recognizable viral determinants. Murali-Krishna K, Ravi V, Manjunath R, Arch Virol 1995 140 127 143 10.1007/BF01309728 7646337
37. Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity. Xu G, Xu X, Li Z, He Q, Wu B, Sun S, Chen H, Vaccine 2004 22 1846 1853 10.1016/j.vaccine.2003.09.015 15121294
38. Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice. Konishi E, Ajiro N, Nukuzuma C, Mason PW, Kurane I, Vaccine 2003 21 3675 3683 10.1016/S0264-410X(03)00382-7 12922097
39. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. Chen HW, Pan CH, Liau MY, Jou R, Tsai CJ, Wu HJ, Lin YL, Tao MH, J Virol 1999 73 10137 10145 10559329
40. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. Lin YL, Chen LK, Liao CL, Yeh CT, Ma SH, Chen JL, Huang YL, Chen SS, Chiang HY, J Virol 1998 72 191 200 9420215
41. Japanese encephalitis virus structural and nonstructural proteins expressed in Escherichia coli induce protective immunity in mice. Tafuku S, Miyata T, Tadano M, Mitsumata R, Kawakami H, Harakuni T, Sewaki T, Arakawa T, Microbes Infect 2012 14 169 176 10.1016/j.micinf.2011.09.004 22001496
42. Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells. Krishna VD, Rangappa M, Satchidanandam V, J Virol 2009 83 4766 4777 10.1128/JVI.01850-08 19264772
43. A conserved predicted pseudoknot in the NS2A-encoding sequence of West Nile and Japanese encephalitis flaviviruses suggests NS1' may derive from ribosomal frameshifting. Firth AE, Atkins JF, Virol J 2009 6 4 10.1186/1743-422X-6-4
44. NS1' of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness. Melian EB, Hinzman E, Nagasaki T, Firth AE, Wills NM, Nouwens AS, Blitvich BJ, Leung J, Funk A, Atkins JF, et al. J Virol 2010 84 1641 1647 10.1128/JVI.01979-09 19906906
45. Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis. Zhang YM, Hayes EP, McCarty TC, Dubois DR, Summers PL, Eckels KH, Chanock RM, Lai CJ, J Virol 1988 62 3027 3031 2969058
46. Mice immunized with recombinant vaccinia virus expressing dengue-4 virus structural proteins with or without nonstructural protein-NS1 are protected against fatal dengue virus encephalitis. Bray M, Zhao BT, Markoff L, Eckels KH, Chanock RM, Lai CJ, J Virol 1989 63 2853 2856 2724416
47. Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection. Eckels KH, Dubois DR, Summers PL, Schlesinger JJ, Shelly M, Cohen S, Zhang YM, Lai CJ, Kurane I, Rothman A, et al. Am J Trop Med Hyg 1994 50 472 478 8166355
48. DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus. Hall RA, Nisbet DJ, Pham KB, Pyke AT, Smith GA, Khromykh AA, Proc Natl Acad Sci USA 2003 100 10460 10464 10.1073/pnas.1834270100 12917491
49. Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice. Yang DK, Kweon CH, Kim BH, Lim SI, Kwon JH, Kim SH, Song JY, Han HR, J Vet Sci 2005 6 125 133 15933432
50. Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis. Watts DM, Tesh RB, Siirin M, Rosa AT, Newman PC, Clements DE, Ogata S, Coller BA, Weeks-Levy C, Lieberman MM, Vaccine 2007 25 2913 2918 10.1016/j.vaccine.2006.08.008 17067727
51. Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene. Ishikawa T, Wang G, Widman DG, Infante E, Winkelmann ER, Bourne N, Mason PW, Vaccine 2011 29 7444 7455 10.1016/j.vaccine.2011.07.058 21798299
52. Preparation and immunogenic properties of a recombinant West Nile subunit vaccine. Lieberman MM, Clements DE, Ogata S, Wang G, Corpuz G, Wong T, Martyak T, Gilson L, Coller BA, Leung J, et al. Vaccine 2007 25 414 423 10.1016/j.vaccine.2006.08.018 16996661
53. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection. Chu JH, Chiang CC, Ng ML, J Immunol 2007 178 2699 2705 17312111